+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
GalNAc-ASO Conjugates Market - Global Forecast 2025-2030- Product Image
GalNAc-ASO Conjugates Market - Global Forecast 2025-2030- Product Image
Sale

GalNAc-ASO Conjugates Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6120836
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

GalNAc-ASO conjugates have rapidly advanced to become a cornerstone technology in oligonucleotide therapeutics, enabling targeted delivery and enhanced clinical outcomes for liver-focused disease management. This market is characterized by innovative conjugation strategies, regulatory momentum, and robust industry collaboration—positioning it for sustained strategic growth and transformation.

Market Snapshot: GalNAc-ASO Conjugates

The GalNAc-ASO conjugate market is undergoing significant evolution, shaped by emerging precision medicine trends, advances in nucleotide chemistry, and supportive regulatory frameworks. Mirroring the growing demand for personalized therapies in hepatic and metabolic conditions, developers are capitalizing on efficient ligand-receptor binding mechanisms and scalable synthesis technologies. As a result, industry stakeholders across biopharmaceuticals, contract development, and supply chain segments are aligning their strategies to capture new opportunities in targeted oligonucleotide therapeutics.

Scope & Segmentation: GalNAc-ASO Conjugate Market

This report provides comprehensive analysis and actionable insights across all core market segments. Key segmentation covers:

  • Indications: Familial Hypercholesterolemia, Primary Hyperoxaluria, Transthyretin Amyloidosis.
  • End Users: Hospitals, Research Institutes, Specialty Clinics.
  • Distribution Channels: Hospital Pharmacy, Online Pharmacy (Mobile App, Website), Retail Pharmacy, Specialty Pharmacy (Community & Mail Order).
  • Routes of Administration: Intravenous Infusion, Subcutaneous Injection.
  • Companies: Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Akcea Therapeutics, AstraZeneca, GlaxoSmithKline.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (such as United Kingdom, Germany, France, Saudi Arabia, South Africa), Asia-Pacific (including China, India, Japan, South Korea, Australia, Singapore).

Key technologies assessed include ligand-conjugate platforms, digital adherence tools, and advanced delivery chemistries. The report reviews regional investment climates and regulatory specifics, shaping entry strategies and partnership models.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Technological innovations such as machine learning-enabled sequence design and improved conjugation chemistries are setting new benchmarks for specificity and patient adherence.
  • Regulatory clarity is supporting accelerated trial initiations, with agencies streamlining review processes for conjugated oligonucleotides.
  • Digital integration is facilitating real-world data collection and dynamic clinical adjustments, optimizing therapeutic impact.
  • Emergent regional manufacturing strategies are enhancing supply chain resilience and reducing logistical risks, particularly in response to evolving global trade landscapes.
  • Diversified distribution channel models and differentiated routes of administration are broadening patient access and convenience, meeting the needs of multiple care settings.
  • Strategic partnerships and licensing agreements are driving cumulative expertise, allowing rapid scaling and improving global commercialization networks.

2025 Tariff Impact: Supply Chain and Cost Structures

The introduction of new United States tariffs in 2025 is prompting developers to revise sourcing and production models for GalNAc-ASO conjugates. Increased costs for specialized nucleotides and reagents are accelerating investments in regional manufacturing and strategic supplier agreements. Enhanced digital tracking systems and scenario-based procurement strategies are mitigating logistical delays and supporting compliance in a fast-changing regulatory environment. These adaptations are strengthening supply chain agility and preserving cost competitiveness for market leaders.

Primary Keyword Spotlight: GalNAc-ASO Conjugates

GalNAc-ASO conjugates remain pivotal in redefining hepatic disease therapies due to their selective delivery and improved safety profiles. As the field matures, factors such as scalable synthesis, robust validation models, and adaptive regulatory approaches continue to drive innovation and differentiation. Industry leaders benefit by integrating emerging digital platforms and sustainable manufacturing to support both commercial growth and environmental objectives.

Methodology & Data Sources: Foundation of Market Insights

The report’s analysis integrates secondary research—including scientific journals, regulatory guidance, and industry white papers—with primary interviews featuring executives, investigators, and experts. Findings are cross-validated through data triangulation, ensuring credible thematic conclusions and unbiased insights to inform strategic decisions.

Why This Report Matters

  • Enables strategic planning with detailed segmentation across indication, end user, distribution, and regional adoption trends.
  • Equips decision-makers to anticipate regulatory shifts and supply chain risks, including tariff impacts and sustainability imperatives.
  • Supports targeted investment and partnership development by benchmarking leading technology platforms and competitive strategies.

Conclusion

This comprehensive review equips senior stakeholders to navigate the evolving GalNAc-ASO conjugate landscape with confidence. By leveraging emerging technologies and adapting to regulatory and supply chain dynamics, organizations position themselves for enhanced patient outcomes and sustained market leadership.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emerging clinical trial results highlighting the superior liver uptake and gene silencing potency of triantennary GalNAc-ASO conjugates
5.2. Optimization of linker chemistry to enhance endosomal escape and intracellular bioavailability of GalNAc-ASO therapeutics
5.3. Strategic partnerships between biotech firms and contract research organizations to accelerate GalNAc-ASO pipeline development
5.4. Regulatory guidelines evolving for GalNAc-ASO conjugate approval with a focus on safety and off-target assessment
5.5. Cost-effective manufacturing scale-up of high-purity GalNAc-ASO conjugates using automated solid-phase synthesis platforms
5.6. Personalized medicine approaches integrating patient-specific biomarkers to tailor GalNAc-ASO dosing regimens in clinical practice
5.7. Intellectual property landscape analysis revealing patent clustering around novel GalNAc ligand scaffolds and conjugation techniques
5.8. Adoption of advanced analytics and AI-driven predictive modeling to optimize in vivo pharmacokinetics of GalNAc-ASO conjugates
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. GalNAc-ASO Conjugates Market, by Indication
8.1. Introduction
8.2. Familial Hypercholesterolemia
8.3. Primary Hyperoxaluria
8.4. Transthyretin Amyloidosis
9. GalNAc-ASO Conjugates Market, by End User
9.1. Introduction
9.2. Hospitals
9.3. Research Institutes
9.4. Specialty Clinics
10. GalNAc-ASO Conjugates Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.2.1. Inpatient Pharmacy
10.2.2. Outpatient Pharmacy
10.3. Online Pharmacy
10.3.1. Mobile App
10.3.2. Website
10.4. Retail Pharmacy
10.5. Specialty Pharmacy
10.5.1. Community Specialty
10.5.2. Mail Order Specialty
11. GalNAc-ASO Conjugates Market, by Route of Administration
11.1. Introduction
11.2. Intravenous Infusion
11.3. Subcutaneous Injection
12. GalNAc-ASO Conjugates Market, by Company
12.1. Introduction
12.2. Alnylam Pharmaceuticals
12.3. Ionis Pharmaceuticals
13. Americas GalNAc-ASO Conjugates Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa GalNAc-ASO Conjugates Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific GalNAc-ASO Conjugates Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Ionis Pharmaceuticals, Inc.
16.3.2. Akcea Therapeutics, Inc.
16.3.3. AstraZeneca PLC
16.3.4. GlaxoSmithKline plc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GALNAC-ASO CONJUGATES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GALNAC-ASO CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GALNAC-ASO CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GALNAC-ASO CONJUGATES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GALNAC-ASO CONJUGATES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. GALNAC-ASO CONJUGATES MARKET: RESEARCHAI
FIGURE 26. GALNAC-ASO CONJUGATES MARKET: RESEARCHSTATISTICS
FIGURE 27. GALNAC-ASO CONJUGATES MARKET: RESEARCHCONTACTS
FIGURE 28. GALNAC-ASO CONJUGATES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GALNAC-ASO CONJUGATES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY FAMILIAL HYPERCHOLESTEROLEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY FAMILIAL HYPERCHOLESTEROLEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY PRIMARY HYPEROXALURIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY PRIMARY HYPEROXALURIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY TRANSTHYRETIN AMYLOIDOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY TRANSTHYRETIN AMYLOIDOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY MOBILE APP, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY MOBILE APP, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY COMMUNITY SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY COMMUNITY SPECIALTY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY MAIL ORDER SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY MAIL ORDER SPECIALTY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY ALNYLAM PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY ALNYLAM PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY IONIS PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GALNAC-ASO CONJUGATES MARKET SIZE, BY IONIS PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS GALNAC-ASO CONJUGATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES GALNAC-ASO CONJUGATES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 108. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 109. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 112. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 113. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 116. CANADA GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 117. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 124. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 125. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 126. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 127. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 132. MEXICO GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 199. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 206. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 207. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 212. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 213. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 214. GERMANY GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 215. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 222. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 223. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 224. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 225. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 226. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 227. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 228. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 229. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 230. FRANCE GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 247. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 248. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 256. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 257. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 262. ITALY GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 263. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 270. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 271. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 272. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 273. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 274. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 275. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 278. SPAIN GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA GALNAC-ASO CONJUGATES MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA GALNAC-ASO CONJUGATES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this GalNAc-ASO Conjugates market report include:
  • Ionis Pharmaceuticals, Inc.
  • Akcea Therapeutics, Inc.
  • AstraZeneca PLC
  • GlaxoSmithKline plc

Related Reports

GalNac Conjugates Market - Global Forecast 2025-2030 - Product Image

GalNac Conjugates Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
GalNAc-siRNA Conjugates Drug Market - Global Forecast 2025-2030 - Product Image

GalNAc-siRNA Conjugates Drug Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
RNA-based Therapeutics - Global Strategic Business Report - Product Image

RNA-based Therapeutics - Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
Nucleic Acid Based Therapeutics - Global Strategic Business Report - Product Image

Nucleic Acid Based Therapeutics - Global Strategic Business Report

  • Report
  • 291 Pages
  • Global
From
RNA Interference- Pipeline Insight, 2025 - Product Image

RNA Interference- Pipeline Insight, 2025

  • Drug Pipelines
  • 204 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.